Overview Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain Status: Completed Trial end date: 2019-01-15 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety NVP-1203 in patients with Acute low back pain Phase: Phase 2 Details Lead Sponsor: Navipharm Corporation